You can buy or sell APEN and other stocks, options, ETFs, and crypto commission-free!
Apollo Endosurgery, Inc. Common Stock, also called Apollo Endosurgery, is a medical technology company, which engages in the design, development, and commercialization of medical devices. Read More It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.
52 Week High
52 Week Low
Seeking AlphaMay 7
Activist investor nominates four board candidates at MiMedx
Institutional investor Prescience Point Capital Management, LLC, together with certain other partnerships, has nominated four "world-class" candidates to the board of directors at MiMedx (OTC:MDXG -3.3% ). The nominees are: consultant and investor M. Kathleen Behrens Wilsey, Ph.D., investor and Elcelyx Therapeutics director Richard Berry, consultant Melvin Keating and Apollo Endosurgery CEO K. Todd Newton. Prescient and the nominees own ~9.98% of the company....
Seeking AlphaMay 5
Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2019 Results - Earnings Call Transcript
Apollo Endosurgery, Inc. (NASDAQ:APEN) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants John Gillings - Investors Relations Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig Hallum Andrew Stafford - Piper Jaffray Operator Good afternoon. My name is Kenzie, and I will be your conference operator today. At this time, I would like to welcome, everyone to the Apollo Endosurgery First Quarter 20...
Associated PressApr 30
Apollo Endosurgery, Inc. to Report First Quarter Results on May 2, 2019
Press release content from Business Wire. The AP news staff was not involved in its creation. Press release content from Business Wire. The AP news staff was not involved in its creation. AUSTIN, Texas--(BUSINESS WIRE)--Apr 30, 2019--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2019 on Thur...
Expected Aug 7, After Hours